Evidence map›Paper›PMID 41381542›Full record

ArticleNature communications2025

Multi-faceted roles of β-arrestins in G protein-coupled receptor endocytosis.

Junke Liu, Li Xue, Magalie A Ravier, Floriane Eshak, Francine C Acher, Anne Goupil-Lamy, Marta Cimadevila, Julia Drube, Carsten Hoffmann, Asuka Inoue and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Junke Liu *Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID http://orcid.org/0000-0002-5962-1931
Li Xue *Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID http://orcid.org/0000-0003-0650-2194
Magalie A RavierInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID http://orcid.org/0000-0001-6607-6559
Floriane EshakSaints-Pères Paris Institute for the Neurosciences, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0003-2748-9398
Francine C AcherSaints-Pères Paris Institute for the Neurosciences, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-5413-4181
Anne Goupil-LamyBiovia Science Council, Dassault Système, Vélizy-Villacoublay, France.
Marta CimadevilaInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Julia DrubeInstitut für Molekulare Zellbiologie, CMB-Center for Molecular Biomedicine; Universitätsklinikum Jena; Friedrich-Schiller-Universität Jena, Jena, Germany.
Carsten HoffmannInstitut für Molekulare Zellbiologie, CMB-Center for Molecular Biomedicine; Universitätsklinikum Jena; Friedrich-Schiller-Universität Jena, Jena, Germany.ORCID http://orcid.org/0000-0003-0884-9300
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.ORCID http://orcid.org/0000-0003-0805-4049
Eric TrinquetCisbio Bioassays, A Company Affiliated with Revvity Health Sciences Inc., Codolet, France.
Elodie DupuisCisbio Bioassays, A Company Affiliated with Revvity Health Sciences Inc., Codolet, France.
Laurent PrézeauInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.ORCID http://orcid.org/0000-0001-9800-1084
Jean-Philippe PinInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France. jean-philippe.pin@igf.cnrs.fr.ORCID http://orcid.org/0000-0002-1423-345X
Philippe RondardInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France. philippe.rondard@igf.cnrs.fr.ORCID http://orcid.org/0000-0003-1134-2738

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-13-RPIB-0009-01Fondation pour la Recherche Médicale (Foundation for Medical Research in France) EQU2023030016470
6 · The paper itself

Abstract

The internalization of G protein-coupled receptors (GPCRs) is a key process limiting cell surface receptor activity, and possibly promoting their intracellular signaling. Dysregulation of this process has been implicated in various diseases. This process is known to result from the recruitment of β-arrestins (βarrs) to the active receptors, although some receptors do not require this for unclear reasons. Here, we clarify the importance of βarrs in the internalization of 60 different GPCRs. We show that βarrs are essential for agonist-induced internalization for only a third of the receptors, half of the GPCRs being partially dependent on βarrs or even independent for endocytosis. Furthermore, we develop several Förster resonance energy transfer (FRET)-based molecular interaction assays to elucidate the molecular mechanism of internalization of the glucagon-like peptide-1 receptor (GLP-1R). We show that GLP-1R internalizes mainly by a βarr-independent mechanism involving the direct binding of the clathrin adaptor protein complex-2 to the receptor. However, when this adaptor protein complex-2-dependent mechanism is affected, the GLP-1R internalization becomes βarr-dependent. It shows that multiple mechanisms regulate the internalization of a specific receptor. Our data highlight the various processes used to control cell surface GPCRs, and open novel possibilities to specifically control their signaling processes.

Indexed as

Arrestinsbeta-ArrestinsEndocytosisReceptors, G-Protein-CoupledAdaptor Protein Complex 2AnimalsFluorescence Resonance Energy TransferGlucagon-Like Peptide-1 ReceptorHEK293 CellsHumansProtein BindingSignal TransductionAdaptor Protein Complex 2Arrestinsbeta-ArrestinsGlucagon-Like Peptide-1 ReceptorReceptors, G-Protein-Coupled

Identifiers

PMID41381542
PMCPMC12799616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.